Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 8/20 | 0.38 |
| ▸ | MAPK9 | P45984 | 7/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.35 |
| ▸ | TUBB | P07437 | 1/20 | 0.35 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.35 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.35 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.35 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.35 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1963659 | 1.00 | CYP11B1 (0.41) | CYP11B1CYP11B2CYP17A1CYP19A1MAOA | |
| SCHEMBL8736819 | 0.96 | CYP11B1 (0.43) | CYP11B1CYP11B2CYP17A1CYP19A1MAOA | |
| SCHEMBL12442771 | 0.94 | CYP17A1 (0.43) | CYP11B1CYP11B2CYP17A1CYP19A1MAPK10 | |
| SCHEMBL6114410 | 0.94 | CYP11B1 (0.40) | CYP11B1CYP11B2CYP17A1CYP19A1MAOA | |
| SCHEMBL12169057 | 0.93 | CYP17A1 (0.41) | CYP11B1CYP11B2CYP17A1CYP19A1MAPK10 | |
| SCHEMBL1963564 | 0.93 | CYP11B1 (0.40) | CYP11B1CYP11B2CYP17A1CYP19A1MAOA | |
| SCHEMBL6114261 | 0.93 | CYP11B1 (0.41) | CYP11B1CYP11B2CYP17A1CYP19A1MAOA | |
| SCHEMBL12098380 | 0.92 | CYP17A1 (0.42) | CYP11B1CYP11B2CYP17A1CYP19A1MAPK10 | |
| SCHEMBL12442658 | 0.91 | CYP17A1 (0.42) | CYP11B1CYP11B2CYP17A1CYP19A1MAOA | |
| SCHEMBL12442767 | 0.91 | CYP17A1 (0.42) | CYP11B1CYP11B2CYP17A1CYP19A1MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2336130-B1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2017-06-28 | — | — | EP | disclosed |
| EP-2336130-B1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2017-06-28 | — | — | EP | disclosed |
| US-20130341604-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2013-12-26 | — | — | US | disclosed |
| US-8586210-B2 | Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-11-19 | — | — | US | disclosed |
| US-8586210-B2 | Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-11-19 | — | — | US | disclosed |
| US-8586210-B2 | Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20110175079-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110175079-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110175079-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| EP-2336130-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110175079-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO2A1, SLCO2B1, SLCO4C1 | CYP11B1 232/4885CYP11B2 449/4885CYP17A1 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.